Please assess the completion status of the following clinical trial:

Trial Title: Nitazoxanide for the Treatment of Prolonged Diarrhea in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with diarrhea ≥3 days but \<30 days duration.~* No visible blood in stool.~Exclusion Criteria:~* Use of any antibacterial, antiparasitic or antiviral drugs within 5 days of enrollment.~* Females who are pregnant, suspected of being pregnant or breastfeeding.~* Serious systemic disorders incompatible with the study.~* History of hypersensitivity to nitazoxanide.~* Patients in whom the possibility of receiving placebo and not being able to receive immediately an effective treatment will be incompatible with the severity of the patient's illness according to the investigator's judgment.~* Patients known to have or suspected of having AIDS or other immune deficiencies.

- Gender: ALL
- Minimum Age: 12 Months
- Maximum Age: 11 Years
- Healthy Volunteers: f

Study Arms:
- Nitazoxanide Suspension (Type: EXPERIMENTAL): Nitazoxanide Oral Suspension 100 mg/5 ml for patients aged 1-3 years or Nitazoxanide Oral Suspension 200 mg/10 ml for patients aged 4-11 years
- Placebo Suspension (Type: PLACEBO_COMPARATOR): Placebo Oral Suspension 5 ml for patients aged 1-3 years and Placebo Oral Suspension 10 ml for patients aged 4-11 years

Based on this trial design, predict the completion outcome and termination type (if applicable).